My Legacy Advisors LLC raised its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 1.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,792 shares of the company’s stock after purchasing an additional 88 shares during the quarter. My Legacy Advisors LLC’s holdings in Procter & Gamble were worth $817,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Procter & Gamble by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 229,794,073 shares of the company’s stock valued at $38,524,976,000 after acquiring an additional 1,592,061 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Procter & Gamble by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 56,472,195 shares of the company’s stock worth $9,457,000,000 after buying an additional 1,267,419 shares in the last quarter. Norges Bank acquired a new position in Procter & Gamble in the 4th quarter worth approximately $5,244,463,000. Northern Trust Corp boosted its stake in Procter & Gamble by 10.1% in the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company’s stock worth $4,928,107,000 after purchasing an additional 2,703,757 shares during the period. Finally, Franklin Resources Inc. boosted its stake in Procter & Gamble by 6.4% in the 4th quarter. Franklin Resources Inc. now owns 20,197,996 shares of the company’s stock worth $3,386,194,000 after purchasing an additional 1,209,275 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
Shares of PG opened at $162.68 on Wednesday. The company has a market capitalization of $381.40 billion, a PE ratio of 25.90, a price-to-earnings-growth ratio of 3.76 and a beta of 0.43. The Procter & Gamble Company has a one year low of $156.58 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The company’s fifty day moving average price is $163.67 and its 200 day moving average price is $167.08.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were issued a dividend of $1.0568 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.01. The ex-dividend date was Monday, April 21st. This represents a $4.23 annualized dividend and a dividend yield of 2.60%. Procter & Gamble’s payout ratio is presently 66.98%.
Insider Transactions at Procter & Gamble
In other news, CEO Jennifer L. Davis sold 1,000 shares of the business’s stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the transaction, the chief executive officer now owns 51,965 shares in the company, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the sale, the insider now owns 25,182 shares in the company, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. Erste Group Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the stock an “overweight” rating in a research report on Friday, April 25th. Barclays reiterated an “equal weight” rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Evercore ISI reiterated an “outperform” rating and issued a $190.00 target price (up previously from $170.00) on shares of Procter & Gamble in a research report on Tuesday, June 3rd. Finally, Bank of America cut their target price on shares of Procter & Gamble from $190.00 to $180.00 and set a “buy” rating for the company in a research report on Friday, April 25th. Eight investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $178.86.
Get Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- Short Selling – The Pros and Cons
- D-Wave Is Soaring—But Is ETF Diversification the Better Strategy?
- ETF Screener: Uses and Step-by-Step Guide
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- Top Stocks Investing in 5G Technology
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.